DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis

(2017) Shi-Lu Chen et al.   Molecular Oncology

Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer

(2017) Shunlin Liu et al.   Oncotarget

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

(2016) C. Elena et al.   BLOOD

Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma

(2016) Martin Mžik et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

(2016) Laura Palomo et al.   Oncotarget

A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers

(2016) Jeannine Diesch et al.   Clinical Epigenetics

Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases

(2015) Laura Palomo et al.   AMERICAN JOURNAL OF HEMATOLOGY

TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia

(2015) J. Yamazaki et al.   CANCER RESEARCH

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

(2015) Xiaoyu Qu et al.   Epigenetics

Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia

(2015) Kristen Meldi et al.   JOURNAL OF CLINICAL INVESTIGATION

Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells

(2015) D H Spencer et al.   LEUKEMIA

Molecular Features and Methylation Status in Early Onset (≤40 Years) Colorectal Cancer: A Population Based, Case-Control Study

(2015) Giulia Magnani et al.   Gastroenterology Research and Practice

Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value

(2015) Clare Stirzaker et al.   Nature Communications

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study

(2014) Emnet A. Wassie et al.   AMERICAN JOURNAL OF HEMATOLOGY

CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression

(2014) Xiaoli Zhao et al.   BRITISH JOURNAL OF HAEMATOLOGY

Comprehensive analysis of DNA methylation data with RnBeads

(2014) Yassen Assenov et al.   NATURE METHODS

Global methylation silencing of clusteredproto-cadheringenes in cervical cancer: serving as diagnostic markers comparable to HPV

(2014) Kai-Hung Wang et al.   Cancer Medicine

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

(2013) E. Such et al.   BLOOD

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

(2013) Raphaël Itzykson et al.   JOURNAL OF CLINICAL ONCOLOGY

Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia

(2013) E Jost et al.   LEUKEMIA

A VARIATIONAL BAYES BETA MIXTURE MODEL FOR FEATURE SELECTION IN DNA METHYLATION STUDIES

(2013) ZHANYU MA et al.   Journal of Bioinformatics and Computational Biology

Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia

(2012) Jumpei Yamazaki et al.   Epigenetics

Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes

(2012) M del Rey et al.   LEUKEMIA

TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia

(2012) Cristina Pérez et al.   PLoS One

Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification

(2012) Ana M Cosialls et al.   Epigenomics

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

(2011) T. Braun et al.   BLOOD

Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome

(2011) Juan Sandoval et al.   Epigenetics

Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia

(2011) Romain Aucagne et al.   JOURNAL OF CLINICAL INVESTIGATION

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

(2010) Michael Grövdal et al.   BRITISH JOURNAL OF HAEMATOLOGY

DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

(2010) Maria E. Figueroa et al.   CANCER CELL

Cytogenetic risk stratification in chronic myelomonocytic leukemia

(2010) E. Such et al.   HAEMATOLOGICA

Epigenetic Changes in the Myelodysplastic Syndrome

(2010) Jean-Pierre Issa   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

(2010) Myunggon Ko et al.   NATURE

Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

(2009) L. Bullinger et al.   BLOOD

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia

(2009) L. Milani et al.   BLOOD

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

(2009) M. E. Figueroa et al.   BLOOD

Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia

(2009) Véronique Gelsi-Boyer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epigenetic inactivation of tumour suppressor geneKLF11in myelodysplastic syndromes

(2009) Anna Potapova et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

(2009) O. Kosmider et al.   HAEMATOLOGICA

DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes

(2009) Lanlan Shen et al.   JOURNAL OF CLINICAL ONCOLOGY

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

(2008) Y. Jiang et al.   BLOOD

Promoter methylation of the Wnt/β-catenin signaling antagonistDkk-3is associated with poor survival in gastric cancer

(2008) Jun Yu et al.   CANCER

Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer

(2008) P. Novak et al.   CANCER RESEARCH

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols